AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18047876 — intervention group
Group type: COMPARATOR
Intervention: Comparison to FIM motor score
Number of subjects: 1769
Study 15951574 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary advice, blood glucose monitoring, and insulin therapy as needed
Number of subjects: 1000
Study 15951574 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 1000
Study 11896093 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy with megestrol acetate
Number of subjects: 719
Study 11896093 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy with an aromatase inhibitor (fadrozole or letrozole)
Number of subjects: 719
Study 11896093 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy (combined response to both interventions)
Number of subjects: 719
Study 9707853 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg/kg/dose 12 hourly for 3 days starting within 6 hours of birth
Number of subjects: 19
Study 9707853 — intervention group
Group type: COMPARATOR
Intervention: Control group (no drug)
Number of subjects: 19
Study 9707853 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone group
Number of subjects: 19
Study 8703654 — intervention group
Group type: EXPERIMENTAL
Intervention: meloxicam
Number of subjects: 12
Study 1973094 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination low sodium, low fat, high fibre diet
Number of subjects: 184
Study 1973094 — intervention group
Group type: COMPARATOR
Intervention: Low fat diet
Number of subjects: 184
Study 1973094 — intervention group
Group type: COMPARATOR
Intervention: High fibre diet
Number of subjects: 184
Study 1973094 — intervention group
Group type: COMPARATOR
Intervention: Low sodium diet
Number of subjects: 184
Study 1973094 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination diet
Number of subjects: 184
Study 7241356 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet (50 mg propiram fumarate)
Number of subjects: 10
Study 7241356 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution (50 mg propiram fumarate)
Number of subjects: 10
Study 7241356 — intervention group
Group type: COMPARATOR
Intervention: Tablet and Solution (comparison)
Number of subjects: 10
Study 31469982 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injections
Number of subjects: 40
Study 31469982 — intervention group
Group type: COMPARATOR
Intervention: Placebo (physiological serum)
Number of subjects: 40
Study 30569304 — intervention group
Group type: EXPERIMENTAL
Intervention: Food supplementation (1500 kcal/d) from 10 weeks of pregnancy through to the end
Number of subjects: 1360
Study 30569304 — intervention group
Group type: COMPARATOR
Intervention: Control (no food supplementation)
Number of subjects: 1360
Study 30569304 — intervention group
Group type: EXPERIMENTAL
Intervention: Food supplementation (1500 kcal/d)
Number of subjects: 1360
Study 27686059 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 160
Study 27686059 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 160
Study 27686059 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium ACE (antioxidants)
Number of subjects: 160
Study 27686059 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 160
Study 26402350 — intervention group
Group type: COMPARATOR
Intervention: Brief motivational interventions (BMIs)
Number of subjects: 969
Study 26402350 — intervention group
Group type: COMPARATOR
Intervention: Single-component BMI focused on correction of misperceptions of descriptive norms
Number of subjects: 969
Study 26402350 — intervention group
Group type: COMPARATOR
Intervention: Single-component BMI focused on the use of protective behavioral strategies
Number of subjects: 969
Study 23852229 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% tea
Number of subjects: 30
Study 23852229 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% neem
Number of subjects: 30
Study 23852229 — intervention group
Group type: COMPARATOR
Intervention: 0.2% chlorhexidine
Number of subjects: 30
Study 21498125 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin sodium 2500 IU s.c. daily, in addition to routine luteal phase support
Number of subjects: 172
Study 19817197 — intervention group
Group type: COMPARATOR
Intervention: Pre-exercise manipulation
Number of subjects: 30
Study 19817197 — intervention group
Group type: COMPARATOR
Intervention: Post-exercise manipulation
Number of subjects: 30
Study 19817197 — intervention group
Group type: EXPERIMENTAL
Intervention: Control group (no intervention)
Number of subjects: 30
Study 20306874 — intervention group
Group type: EXPERIMENTAL
Intervention: In-class content delivery
Number of subjects: 0
Study 20306874 — intervention group
Group type: EXPERIMENTAL
Intervention: At-home study packets
Number of subjects: 0
Study 20306874 — intervention group
Group type: EXPERIMENTAL
Intervention: Online modules
Number of subjects: 0
Study 15733878 — intervention group
Group type: EXPERIMENTAL
Intervention: Foley catheter
Number of subjects: 140
Study 15733878 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronidase
Number of subjects: 140
Study 12409165 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline depressive symptoms
Number of subjects: 80
Study 12409165 — intervention group
Group type: COMPARATOR
Intervention: Baseline PANSS depression factor scores
Number of subjects: 80
Study 10220004 — intervention group
Group type: EXPERIMENTAL
Intervention: Early sleep deprivation (ESD)
Number of subjects: 41
Study 10220004 — intervention group
Group type: EXPERIMENTAL
Intervention: Late sleep deprivation (LSD)
Number of subjects: 41
Study 10220004 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery sleep after ESD (ESD-R)
Number of subjects: 41
Study 10220004 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery sleep after LSD (LSD-R)
Number of subjects: 41
Study 10220004 — intervention group
Group type: COMPARATOR
Intervention: Baseline sleep EEG measures
Number of subjects: 41
Study 7596934 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (12.5 mg bid)
Number of subjects: 80
Study 7596934 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (2.5 mg bid)
Number of subjects: 80
Study 2212184 — intervention group
Group type: EXPERIMENTAL
Intervention: hero/heroine intervention
Number of subjects: 90
Study 2212184 — intervention group
Group type: COMPARATOR
Intervention: control group
Number of subjects: 90
Study 619842 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy plus drugs
Number of subjects: 0
Study 619842 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs
Number of subjects: 0
Study 619842 — intervention group
Group type: COMPARATOR
Intervention: Five different treatment methods
Number of subjects: 0
Study 12100441 — intervention group
Group type: EXPERIMENTAL
Intervention: CQ + SP administered sequentially (CQ0 + SP4)
Number of subjects: 32
Study 12100441 — intervention group
Group type: EXPERIMENTAL
Intervention: CQ + SP administered simultaneously (CQ0 + SP0)
Number of subjects: 32
Study 12100441 — intervention group
Group type: COMPARATOR
Intervention: CQ + SP0
Number of subjects: 32
Study 12100441 — intervention group
Group type: COMPARATOR
Intervention: CQ + SP4
Number of subjects: 32
Study 30001723 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder and recall intervention
Number of subjects: 0
Study 30001723 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit and feedback with education intervention
Number of subjects: 0
Study 30001723 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention (reminder and recall + audit and feedback with education)
Number of subjects: 0
Study 30001723 — intervention group
Group type: COMPARATOR
Intervention: Current course of care (control)
Number of subjects: 0
Study 26947795 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedal pulse palpation test
Number of subjects: 18681
Study 26947795 — intervention group
Group type: EXPERIMENTAL
Intervention: Four palpable pulses
Number of subjects: 18681
Study 24920915 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg twice daily)
Number of subjects: 557
Study 24920915 — intervention group
Group type: COMPARATOR
Intervention: Gliclazide plus metformin
Number of subjects: 557
Study 24920915 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 557
Study 23365521 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Training (ST)
Number of subjects: 21
Study 23365521 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Training with Whole-Body Vibration (ST + V)
Number of subjects: 21
Study 23365521 — intervention group
Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 21
Study 19662486 — intervention group
Group type: EXPERIMENTAL
Intervention: 585-nm pulsed dye laser (PDL) with a pulse duration of 450 micros
Number of subjects: 20
Study 19662486 — intervention group
Group type: EXPERIMENTAL
Intervention: 585-nm pulsed dye laser (PDL) with a pulse duration of 1.5 ms
Number of subjects: 20
Study 19662486 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20
Study 18619813 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil-based lipid emulsion (ClinOleic)
Number of subjects: 78
Study 18619813 — intervention group
Group type: COMPARATOR
Intervention: Soybean oil-based lipid emulsion (Intralipid)
Number of subjects: 78
Study 15687338 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - conjugated estrogens (0.625 mg) plus medroxyprogesterone acetate (2.5 mg)
Number of subjects: 76
Study 15687338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 11902622 — intervention group
Group type: EXPERIMENTAL
Intervention: High suppressors
Number of subjects: 1504
Study 11902622 — intervention group
Group type: COMPARATOR
Intervention: Low suppressors
Number of subjects: 1504
Study 11902622 — intervention group
Group type: EXPERIMENTAL
Intervention: General participants
Number of subjects: 1504
Study 11902622 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants evaluating scenarios of discrimination
Number of subjects: 1504
Study 11902622 — intervention group
Group type: EXPERIMENTAL
Intervention: Suppression scales
Number of subjects: 1504
Study 9915375 — intervention group
Group type: EXPERIMENTAL
Intervention: Right half-field patches (n = 7)
Number of subjects: 22
Study 9915375 — intervention group
Group type: EXPERIMENTAL
Intervention: Right monocular patch (n = 7)
Number of subjects: 22
Study 9915375 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 8)
Number of subjects: 22
Study 7770309 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutramigen
Number of subjects: 285
Study 7770309 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSobee
Number of subjects: 285
Study 7770309 — intervention group
Group type: EXPERIMENTAL
Intervention: Enfamil with Iron, ProSobee, Nutramigen
Number of subjects: 285
Study 7770309 — intervention group
Group type: COMPARATOR
Intervention: All formula groups
Number of subjects: 285
Study 2110338 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 1.5 mg/70 kg, intramuscularly
Number of subjects: 7
Study 2110338 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 3.0 mg/70 kg, intramuscularly
Number of subjects: 7
Study 2110338 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 6.0 mg/70 kg, intramuscularly
Number of subjects: 7
Study 2110338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 543889 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin 3 g + Oxacillin 2 g
Number of subjects: 0
Study 543889 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin 2 g + Oxacillin 1 g
Number of subjects: 0
Study 543889 — intervention group
Group type: EXPERIMENTAL
Intervention: Mezlocillin 3.75 g + Oxacillin 1.25 g
Number of subjects: 0
Study 543889 — intervention group
Group type: EXPERIMENTAL
Intervention: Mezlocillin 2 g + Oxacillin 1 g
Number of subjects: 0
Study 543889 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbenicillin 7.5 g + Oxacillin 2.5 g
Number of subjects: 0
Study 543889 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of penicillins
Number of subjects: 0
Study 543889 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxacillin 2.5 g + Carbenicillin 7.5 g
Number of subjects: 0
Study 30663401 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive interventions for engaging patients in treatment
Number of subjects: 0
Study 30663401 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed analysis method for repeated binary outcomes
Number of subjects: 0
Study 30397008 — intervention group
Group type: EXPERIMENTAL
Intervention: Development model
Number of subjects: 1266
Study 30397008 — intervention group
Group type: EXPERIMENTAL
Intervention: External validation model
Number of subjects: 1266
Study 30397008 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline model
Number of subjects: 1266
Study 30397008 — intervention group
Group type: EXPERIMENTAL
Intervention: Updated model
Number of subjects: 1266
Study 27571011 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD
Number of subjects: 1116
Study 27571011 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1116
Study 25261145 — intervention group
Group type: EXPERIMENTAL
Intervention: Music (Group M)
Number of subjects: 75
Study 25261145 — intervention group
Group type: COMPARATOR
Intervention: White noise (Group B)
Number of subjects: 75
Study 25261145 — intervention group
Group type: COMPARATOR
Intervention: Ambient noise (Group O)
Number of subjects: 75
Study 22563197 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced volume method (Group A) - did not drink PEG‐ELS the day before; drank 2 L on procedure day.
Number of subjects: 64
Study 22563197 — intervention group
Group type: COMPARATOR
Intervention: Conventional volume method (Group B) - drank 2 L PEG‐ELS the day before; drank 1 L on procedure day.
Number of subjects: 64
Study 22563197 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced volume method (Group A) - 31 subjects.
Number of subjects: 64
Study 22563197 — intervention group
Group type: COMPARATOR
Intervention: Conventional volume method (Group B) - 29 subjects.
Number of subjects: 64
Study 22563197 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups received boosters of magnesium citrate.
Number of subjects: 64
Study 22563197 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse event reported in Group A.
Number of subjects: 64
Study 20207721 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (APAP) 15 mg/kg with 100% RDA for SAA
Number of subjects: 0
Study 20207721 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (APAP) with 0% RDA for SAA
Number of subjects: 0
Study 20207721 — intervention group
Group type: COMPARATOR
Intervention: 0% RDA for SAA without APAP
Number of subjects: 0
Study 17684986 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled epidural analgesia (PCEA) with fentanyl, 2 microg/ml, in 0.2% bupivacaine solution (Group 1)
Number of subjects: 90
Study 17684986 — intervention group
Group type: COMPARATOR
Intervention: Bolus infections of fentanyl, 2 microg/ml, in 0.2% bupivacaine solution (Group 2)
Number of subjects: 90
Study 17684986 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural infusion of fentanyl, 2 microg/ml, in 0.2% bupivacaine solution (Group 3)
Number of subjects: 90
Study 15685505 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 0
Study 15685505 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0
Study 15685505 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 11471080 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing 34 pools of 5 specimens each
Number of subjects: 170
Study 11471080 — intervention group
Group type: COMPARATOR
Intervention: Testing all 170 specimens individually
Number of subjects: 170
Study 11471080 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooling 14 specimens per test
Number of subjects: 170
Study 11471080 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooling 2 samples per test
Number of subjects: 170
Study 9922856 — intervention group
Group type: EXPERIMENTAL
Intervention: Trinipatch (5 mg/24 h and 10 mg/24 h)
Number of subjects: 5078
Study 7804442 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone (4 mg for adults, 2 mg/m2 for children)
Number of subjects: 30
Study 7804442 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dexamethasone (8 mg for adults, 4 mg for children)
Number of subjects: 30
Study 3051324 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatic glucagon (G)
Number of subjects: 9
Study 3051324 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-21 fragment of pancreatic glucagon (G 1-21)
Number of subjects: 9
Study 3051324 — intervention group
Group type: COMPARATOR
Intervention: Physiologic saline (Control)
Number of subjects: 9
Study 30691671 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 T lung magnetic resonance imaging (MRI)
Number of subjects: 27
Study 28357975 — intervention group
Group type: EXPERIMENTAL
Intervention: MicroExpression Training Tool (METT), twice weekly for 4 weeks
Number of subjects: 22
Study 28357975 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 22
Study 26610598 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 23
Study 26610598 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 23850170 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary surgery
Number of subjects: 670
Study 23850170 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 670
Study 23850170 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 670
Study 23850170 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment selection based on biomarkers
Number of subjects: 670
Study 21463154 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous repair
Number of subjects: 279
Study 21463154 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 279
Study 19567516 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 mg oral vitamin D(3) (n = 8)
Number of subjects: 17
Study 19567516 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 mg oral vitamin D(2) (n = 9)
Number of subjects: 17
Study 19567516 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 17
Study 16978615 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound, biopsy, blood sampling, In vitro fertilization-ET in the following cycle
Number of subjects: 96
Study 16978615 — intervention group
Group type: COMPARATOR
Intervention: Fertile controls
Number of subjects: 96
Study 15365313 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (1.0 g/kg)
Number of subjects: 14
Study 15365313 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy drink (3.57 ml/kg Red Bull)
Number of subjects: 14
Study 15365313 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol + energy drink
Number of subjects: 14
Study 15365313 — intervention group
Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 14
Study 10931079 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (1000 mg) + oral levonorgestrel (250 microg daily)
Number of subjects: 28
Study 10931079 — intervention group
Group type: COMPARATOR
Intervention: Testosterone undecanoate (1000 mg) + oral placebo
Number of subjects: 28
Study 9262873 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning gymnastic time (09:00 to 10:00)
Number of subjects: 130
Study 9262873 — intervention group
Group type: COMPARATOR
Intervention: Afternoon gymnastic time (14:00 to 15:00)
Number of subjects: 130
Study 9262873 — intervention group
Group type: EXPERIMENTAL
Intervention: Gym (without consideration of time)
Number of subjects: 130
Study 9262873 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger subjects (6-7 years)
Number of subjects: 130
Study 7876402 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabumetone (NAB) 1000 mg daily
Number of subjects: 14
Study 7876402 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (IND) 50 mg every 12 hours
Number of subjects: 14
Study 7876402 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac (SUL) 200 mg every 12 hours
Number of subjects: 14
Study 3277486 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine
Number of subjects: 18
Study 3277486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 31770016 — intervention group
Group type: EXPERIMENTAL
Intervention: Scutellaria baicalensis (SB) 3.52 g/day
Number of subjects: 0
Study 31770016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29615378 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative fascia iliaca compartment block (FICB)
Number of subjects: 50
Study 29615378 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative surgeon-delivered psoas compartment block (PCB)
Number of subjects: 50
Study 28654569 — intervention group
Group type: EXPERIMENTAL
Intervention: State Behavioral Scale (SBS)
Number of subjects: 226
Study 28654569 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal Assessment Tool‐Version 1 (WAT‐1)
Number of subjects: 226
Study 28654569 — intervention group
Group type: EXPERIMENTAL
Intervention: Glasgow Coma Scale
Number of subjects: 226
Study 25794355 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-4-3-2-1 Go! obesity prevention program exposure
Number of subjects: 246
Study 25794355 — intervention group
Group type: COMPARATOR
Intervention: Control condition (not specified)
Number of subjects: 246
Study 23819242 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint injection with small dose of fentanyl-droperido mixed liquor
Number of subjects: 150
Study 23819242 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous injection with fentanyl-droperido mixed liquor
Number of subjects: 150
Study 23819242 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous injection of 0.9% NaCl
Number of subjects: 150
Study 21059094 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin 1 mg
Number of subjects: 333
Study 21059094 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin 5 mg
Number of subjects: 333
Study 21059094 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin 10 mg
Number of subjects: 333
Study 21059094 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride (1-3 mg)
Number of subjects: 333
Study 21059094 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 333